Creon DR 36,000 unit capsule UU 100S
Ended Awarded
- Contract number
- SPE2DR26F80LP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,695
Award facts
- Contract value 100% obligated
- $8,695.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $8,695.12 delivery order to Amerisourcebergen Drug Corp on July 9, 2026, for 36,000 unit capsules of Creon (pancreatic enzyme replacement therapy).
Place of performance is Conshohocken, PA. The order has a firm fixed-price structure and an ultimate completion date of July 10, 2026. No set-aside applied to this award. The parent vehicle information is not specified in the source.
Quick answers
Who was awarded contract SPE2DR26F80LP?
SPE2DR26F80LP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 9, 2026.
How much is contract SPE2DR26F80LP worth?
The government has obligated $8,695 on SPE2DR26F80LP.
Is contract SPE2DR26F80LP an order under another contract?
Yes. SPE2DR26F80LP is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F80LP competed?
The extent of competition for SPE2DR26F80LP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award